Canadian Institutes of Health Research
9
937K
9
0.39
3
4
- Areas of investment
Summary
Canadian Institutes of Health Research appeared to be the Corporate Investor, which was created in 2000. The company was established in North America in Canada. The leading representative office of defined Corporate Investor is situated in the Ottawa.
Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Among the various public portfolio startups of the fund, we may underline ProMIS Neurosciences
This organization was formed by Patrick Neary.
The standard case for the fund is to invest in rounds with 1 partaker.
The usual things for fund are deals in the range of 100 thousands - 1 million dollars. The important activity for fund was in 2017. The top amount of exits for fund were in 2007. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 3
- Exits
- 4
- Rounds per year
- 0.39
- Investments by industry
- Biotechnology (7)
- Health Care (4)
- Medical (3)
- Health Diagnostics (3)
- Therapeutics (2) Show 6 more
- Investments by region
-
- United States (1)
- Canada (7)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.22
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.